Home Stocks Ajanta Pharma Ltd

Ajanta Pharma Ltd

The live share price of Ajanta Pharma Ltd (AJANTPHARM) as on 04 Oct 10:14am is ₹1,774.75 from NSE/BSE.

AJANTPHARM NSE

₹1,774.75 ▼-0.95% (-17.05)

As on Oct 04, 2023 03:44 PM IST

How do you feel today about Ajanta Pharma Ltd?

Bearish or

Bullish

Bearish or

Bullish

Key Metrics

PE Ratio

36.47

PB Ratio

6.69

Dividend Yield

0.39%

Sector PB

4.77

Sector PE

40.65

Sector Div Yld

0.76%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Midcap, ₹22,663 Cr

Ajanta Pharma Limited is a specialty pharmaceutical company engaged in developing, producing and marketing a range of branded and generic formulations.

The following charts display the financial performance of the Ajanta Pharma Ltd (AJANTPHARM) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Ajanta Pharma Ltd (AJANTPHARM), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Midcap, ₹22,663 Cr

Financials

Income Statement

(INR)		Y/Y Change
Revenue	3,841 Cr	+11.13%
Operating Expense	298 Cr	+108.5%
Net Income	587 Cr	-17.5%
Net Profit Margin	15.31%	-25.75%
Earning Per Share	45	-16.13%
EBITDA	881 Cr	-15.61%

Balance sheet

(INR)		Y/Y Change
Cash & short-term Inv	841 Cr	+152.11%
Total Assets	4,582 Cr	+14.56%
Total Liabilities	1,194 Cr	+62.33%
Total Equity	3,387 Cr	+3.79%
Shares Outstanding	12.67 Cr	-1.99%
Price to Book	4.52	-3.6%
Return on Assets	13.7%	-25.7%
Return on Capital	22.17 Cr	-21.3%

Cash Flows

(INR)		Y/Y Change
Net Income	587 Cr	-17.5%
Cash from Operations	791 Cr	+40.96%
Cash from Investing	-559 Cr	+655.2%
Cash from Financing	-107 Cr	-76.54%
Net Change in Cash	124 Cr	+345.56%
Free Cash Flow	617 Cr	+49.51%

Shareholding Pattern

Total Promoter Holding

66.21%

Unpledged

Foreign Institutions

10.19%

Foreign Institutions

Retail & Others

7.78%

Retail & Others

Other Parties

Other Domestic Institutions

2.75%

Insurance Firms

Others

Mutual Funds

13.07%

Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

32.96

1Y Return

▲20.85%

CIPLA

Cipla Ltd

PE Ratio

30.78

1Y Return

▲4.6%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

19.69

1Y Return

▲23.58%

MANKIND

Mankind Pharma Ltd

PE Ratio

48.72

1Y Return

▲26.44%

Latest News

Pharma Key Molecule Check - Traction In Key Dr. Reddy’s, Lupin, Ajanta Pharma Products: Yes Securities

7 days ago on Bloomberg Quint

Change since news ▼-2.31%

Ajanta Pharma has seen market share gains across top products which should aid base business.

Ajanta Pharma Shares At All-Time High After August Sales Data

3 weeks ago on Bloomberg Quint

Change since news ▼-3.44%

Ajanta Pharma ‘outperformed’ the market, led by ophthalmology therapy, pain therapy, and dermatology, Motilal Oswal said.

Stocks In Focus | Zomato, Sula, BHEL, RVNL, Ajanta Pharma & More | BQ Prime

1 month ago on Bloomberg Quint

Change since news ▼-2.7%

Stocks In Focus | Zomato, Sula, BHEL, RVNL, Ajanta Pharma & More | BQ Prime #StocksInFocus | Sharmila Joshi shares insights on #Zomato, #Sula, #BHEL, #RVNL and other stocks to watch in trade today.

FAQs on Ajanta Pharma Ltd

How to buy Ajanta Pharma Ltd stocks?

You can easily buy the stocks/shares of Ajanta Pharma Ltd (AJANTPHARM) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Ajanta Pharma Ltd?

The stock price of Ajanta Pharma Ltd as on 04 Oct 2023 is ₹1,774.75

What is the 52-week High and Low of Ajanta Pharma Ltd?

The 52-week high and low of Ajanta Pharma Ltd (AJANTPHARM) is ₹1,904.45 and ₹1,111.6.

What is the PE and PB ratio of Ajanta Pharma Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Ajanta Pharma Ltd are 36.47 and 6.69 respectively.

What are the peers or stocks similar to Ajanta Pharma Ltd?

The peers or stocks similar to Ajanta Pharma Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Mankind Pharma Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Ajanta Pharma Ltd belong to?

Ajanta Pharma Ltd (AJANTPHARM) belongs to the Pharmaceuticals sector.

What is the Market Cap of Ajanta Pharma Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ajanta Pharma Ltd (AJANTPHARM) is ₹22,663 Cr as of 04 Oct 2023

Can't decide whether or not to buy Ajanta Pharma Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.

Dislaimer: This platform is intended for informational purposes only and is not intended to provide investment advice. The stock prices displayed are delayed and may not reflect the most current market conditions. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. You can also consider consulting a financial advisor before making any investment decisions. Smallcase Technologies Private Limited shall not be responsible for any losses that may occur as a result of using this platform.